ADx NeuroSciences

Always up-to-date of the latest developments

NewsPublications
23 June 2022

Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry

Gent, Belgium and Tokyo, Japan, June 23, 2022 – H.U.…
ADx admin
NewsPublications
28 January 2022

Scientific articles in 2022

New year, new research! In 2022 ADx will continue to…
ADx admin
NewsEvents
19 January 2022

ADx NeuroSciences’ review of 2021

2021 was a remarkable year for ADx. Check out our…
ADx admin
NewsPublications
18 January 2022

Scientific articles in 2021

In 2021, ADx NeuroSciences' collaborators worked intensively on groundbreaking scientific…
Nele
NewsPublications
31 December 2020

Scientific articles in 2020

In 2020, ADx NeuroSciences' collaborators have been intensively participating in…
ADx admin
NewsEvents
1 July 2020

ADx will be present at the upcoming virtual AAIC 2020

Discover the new findings in blood and synaptic biomarkers at…
Nele
NewsEvents
9 April 2020

Cancellation ADx Neuro Biomarker Conference

We regret to announce that the ADx Neuro Biomarker Conference…
Nele
NewsEvents
2 April 2020

ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.

While the classical fluid markers, tau and amyloid, accord well…
Nele
NewsPublications
31 December 2019

Scientific articles in 2019

In 2019, ADx NeuroSciences' collaborators were intensively participating in groundbreaking…
ADx admin
NewsEvents
11 December 2019

Present at CTAD 2019

ADx NeuroSciences will be present at CTAD. You can reach…
Nele
News
10 December 2019

ADx receives funding from Bill Gates for developing blood biomarkers

Together with Douglas Galasko, M.D. University of California at San…
Nele
NewsPublications
31 December 2018

Scientific articles in 2018

ADx NeuroSciences is an R&D company and its people are…
ADx admin